| Citation: | Qiu Sangsang, Xu Qinfen, Huang Qinhong, et al. Application of multi-disciplinary team mode in prevention and control of multidrug resistant organism infection in lung transplant recipients[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024008
|
| [1] |
CHANG SH, CHAN J, PATTERSON GA. History of lung transplantation[J]. Clin Chest Med, 2023, 44(1): 1-13. DOI: 10.1016/j.ccm.2022.11.004.
|
| [2] |
LOOR G, MATTAR A, SCHAHEEN L, et al. Surgical complications of lung transplantation[J]. Thorac Surg Clin, 2022, 32(2): 197-209. DOI: 10.1016/j.thorsurg.2022.01.003.
|
| [3] |
JOEAN O, WELTE T, GOTTLIEB J. Chest infections after lung transplantation[J]. Chest, 2022, 161(4): 937-948. DOI: 10.1016/j.chest.2021.10.014.
|
| [4] |
赵键. 多重耐药菌流行现状、耐药机制及其治疗策略[J]. 济宁医学院学报, 2023, 46(3): 216-220. DOI: 10.3969/j.issn.1000-9760.2023.03.014.
ZHAO J. Current situation, resistance mechanisms and treatment strategies of multidrug-resistant bacteria[J]. J Jining Med Univ, 2023, 46(3): 216-220. DOI: 10.3969/j.issn.1000-9760.2023.03.014.
|
| [5] |
SY CL, CHEN PY, CHENG CW, et al. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms[J]. J Microbiol Immunol Infect, 2022, 55(3): 359-386. DOI: 10.1016/j.jmii.2022.02.001.
|
| [6] |
HONG NGUYEN M, SHIELDS RK, CHEN L, et al. Molecular epidemiology, natural history, and long-term outcomes of multidrug-resistant enterobacterales colonization and infections among solid organ transplant recipients[J]. Clin Infect Dis, 2022, 74(3): 395-406. DOI: 10.1093/cid/ciab427.
|
| [7] |
BEZINOVER D, BIANCOFIORE G, FALCONE M, et al. Multidrug-resistant infections in solid organ transplant recipients: a focus on risk factors, prevention, and treatment strategies[J]. Minerva Anestesiol, 2022, 88(9): 735-747. DOI: 10.23736/S0375-9393.22.16124-9.
|
| [8] |
WONG D, VAN DUIN D. Carbapenemase-producing organisms in solid organ transplantation[J]. Curr Opin Organ Transplant, 2019, 24(4): 490-496. DOI: 10.1097/MOT.0000000000000664.
|
| [9] |
VAN DUIN D, DOI Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae[J]. Virulence, 2017, 8(4): 460-469. DOI: 10.1080/21505594.2016.1222343.
|
| [10] |
黄丽华, 刘娇, 彭雪儿, 等. 2019~2021年某肿瘤专科医院院内感染情况分析[J]. 中山大学学报(医学科学版), 2023, 44(4): 697-703. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20230409.002.
HUANG LH, LIU J, PENG XE, et al. Analysis of Nosocomial Infection in a Cancer Hospital from 2019 to 2021[J]. J Sun Yat-sen Univ (Med Sci), 2023, 44(4): 697-703. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20230409.002.
|
| [11] |
陈美利, 景照峰, 黄合田, 等. 某三级综合医院多重耐药菌防控管理新模式探讨[J]. 中国感染控制杂志, 2023, 22(8): 925-931. DOI: 10.12138/j.issn.1671-9638.2023 4240.
CHEN ML, JING ZF, HUANG HT, et al. A new management mode for the prevention and control of multidrug-resistant organisms in a tertiary hospital[J]. Chin J Infect Control, 2023, 22(8): 925-931. DOI: 10.12138/j.issn.1671-9638.20234240.
|
| [12] |
KANJ SS, BASSETTI M, KIRATISIN P, et al. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections[J]. Int J Antimicrob Agents, 2022, 60(3): 106633. DOI: 10.1016/j.ijantimicag.2022.106633.
|
| [13] |
BARBER KE, WAGNER JL, LARRY RC, et al. Frequency of and risk factors for carbapenem-resistant enterobacteriaceae[J]. J Med Microbiol, 2021, 70(2): 001286. DOI: 10.1099/jmm.0.001286.
|
| [14] |
DAWSON C, ROE J, STARMER H, et al. Patient advocacy in head and neck cancer: realities, challenges and the role of the multi-disciplinary team[J]. Clin Otolaryngol, 2020, 45(4): 437-444. DOI: 10.1111/coa.13508.
|
| [15] |
商冠宁. 多学科综合诊疗协作组模式在骨肿瘤规范化诊疗中的应用[J]. 中国肿瘤外科杂志, 2022, 14(5): 417-420. DOI: 10.3969/j.issn.1674-4136.2022.05.001.
SHANG GN. Application of MDT model in standardized diagnosis and treatment of bone tumors[J]. Chin J Surg Oncol, 2022, 14(5): 417-420. DOI: 10.3969/j.issn.1674-4136.2022.05.001.
|
| [16] |
中国抗癌协会妇科肿瘤专业委员会, 中国抗癌协会肿瘤多学科诊疗(MDT)专业委员会, 中国医师协会肿瘤多学科诊疗专业委员会. 妇科恶性肿瘤多学科诊疗中国专家共识(2022年版)[J]. 中国癌症杂志, 2022, 32(8): 747-756. DOI: 10.19401/j.cnki.1007-3639.2022.08.010.
The Society of Gynecological Cancer of China Anti-Cancer Association, Multidisciplinary Diagnosis and Treatment (MDT) Committee of China Anti-Cancer Association, Multidisciplinary Cancer Diagnosis and Treatment Committee of Chinese Medical Doctor Association. Consensus of Chinese experts on multidisciplinary team of gynecological malignant tumors (2022 edition)[J]. China Oncol, 2022, 32(8): 747-756. DOI: 10.19401/j.cnki.1007-3639.2022.08.010.
|
| [17] |
BOUCHAND F, DINH A, ROUX AL, et al. Implementation of a simple innovative system for postprescription antibiotic review based on computerized tools with shared access[J]. J Hosp Infect, 2017, 95(3): 312-317. DOI: 10.1016/j.jhin.2016.11.011.
|
| [18] |
JENKINS N, HUGHES H. How I do it…. how infection doctors approach the PJI MDT[J]. Knee, 2020, 27(6): 1994-1997. DOI: 10.1016/j.knee.2020.09.005.
|
| [19] |
白镓玮, 马承泰, 吴淼, 等. 肺移植术后多重耐药菌感染的防治研究进展[J]. 武汉大学学报(医学版), 2021, 42(4): 551-557. DOI: 10.14188/j.1671-8852.2021.6010.
BAI JW, MA CT, WU M, et al. Research progress in the prevention and treatment of multidrug-resistant organisms infection after lung transplantation[J]. Med J Wuhan Univ, 2021, 42(4): 551-557. DOI: 10.14188/j.1671-8852.2021.6010.
|
| [20] |
蔡小军, 宋惠珠, 焦正, 等. 242例肺移植受者的感染病原菌分布及耐药特征分析[J]. 中华器官移植杂志, 2017, 38(9): 513-519. DOI: 10.3760/cma.j.issn.0254-1785.2017.09.001.
CAI XJ, SONG HZ, JIAO Z, et al. Distribution and drug resistance characteristics of pathogens for infection after lung transplantation from 2010 to 2016[J]. Chin J Organ Transplant, 2017, 38(9): 513-519. DOI: 10.3760/cma.j.issn.0254-1785.2017.09.001.
|
| [21] |
蔡虻, 刘聚源. 多重耐药菌医院感染防控策略与思考[J]. 中国护理管理, 2018, 18(12): 1590-1594. DOI: 10.3969/j.issn.1672-1756.2018.12.002.
CAI M, LIU JY. Thinking on the strategy on prevention and control of Multidrug-Resistant Organism healthcare-associated infection[J]. Chin Nurs Manag, 2018, 18(12): 1590-1594. DOI: 10.3969/j.issn.1672-1756.2018.12.002.
|
| [22] |
裴媛玲, 周丽清, 刘淑萍, 等. 多重耐药菌感染防控中全程标准化流程管理的构建及效果[J]. 基层医学论坛, 2023, 27(18): 123-125. DOI: 10.19435/j.1672-1721.2023. 18.039.
PEI YL, ZHOU LQ, LIU SP, et al. Construction and effectiveness of standardized process management for the prevention and control of multidrug-resistant bacterial infections[J]. Med Forum, 2023, 27(18): 123-125. DOI: 10.19435/j.1672-1721.2023.18.039.
|
| [23] |
ABAD CL, BARKER AK, SAFDAR N. A systematic review of the effectiveness of cohorting to reduce transmission of healthcare-associated C. difficileand multidrug-resistant organisms[J]. Infect Control Hosp Epidemiol, 2020, 41(6): 691-709. DOI: 10.1017/ice.2020.45.
|
| [24] |
DOUGLAS AP, STEWART AG, HALLIDAY CL, et al. Outbreaks of fungal infections in hospitals: epidemiology, detection, and management[J]. J Fungi (Basel), 2023, 9(11): 1059. DOI: 10.3390/jof9111059.
|
| [25] |
邓晓辉, 康亚辉, 贺锐, 等. 多层级多学科综合治疗模式对院内感染防控的结果分析[J]. 中国妇幼保健, 2022, 37(13): 2493-2496. DOI: 10.19829/j.zgfybj.issn.1001-4411.2022.13.045.
DENG XH, KANG YH, HE R, et al. Analysis on the prevention and control effect of multi-level and multi-disciplinarity comprehensive treatment model on hospital infection[J]. Matern Child Health Care China, 2022, 37(13): 2493-2496. DOI: 10.19829/j.zgfybj.issn.1001-4411.2022.13.045.
|
| [26] |
燕超, 齐金龙, 刘莉. 多学科协作在儿童多重耐药菌医院感染防控中的应用[J]. 生命科学仪器, 2022, 20(z1): 390. DOI: 10.11967/2022006166.
YAN C, QI JL, LIU L. Application of multidisciplinary collaboration in hospital infection prevention and control of multidrug-resistant bacteria in children[J]. Life Sci Instrum, 2022, 20(z1): 390. DOI: 10.11967/2022006166.
|
| [27] |
KELLY BJ, BEKELE S, LOUGHREY S, et al. Healthcare microenvironments define multidrug-resistant organism persistence[J]. Infect Control Hosp Epidemiol, 2022, 43(9): 1135-1141. DOI: 10.1017/ice.2021.323.
|
| [28] |
PETERS A, SCHMID MN, PARNEIX P, et al. Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review[J]. Antimicrob Resist Infect Control, 2022, 11(1): 38. DOI: 10.1186/s13756-022-01075-1.
|
| [29] |
CRUZ-LÓPEZ F, MARTÍNEZ-MELÉNDEZ A, VILLARREAL-TREVIÑO L, et al. Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii[J]. Am J Med Sci, 2022, 364(6): 685-694. DOI: 10.1016/j.amjms.2022.07.003.
|
| [30] |
TENG J, IMANI S, ZHOU A, et al. Combatting resistance: understanding multi-drug resistant pathogens in intensive care units[J]. Biomed Pharmacother, 2023, 167: 115564. DOI: 10.1016/j.biopha.2023.115564.
|
| [31] |
USHIRO-LUMB I, THORBURN D. Risk of transmission of infections to others after donor-derived infection transmissions[J]. Transpl Infect Dis, 2022, 24(2): e13791. DOI: 10.1111/tid.13791.
|
| [32] |
ZHOU WY, SHEN L, SHI JX, et al. Real-time, random-access organ screening for carbapenem-resistant organisms (CRO) reduces CRO-associated, donor-derived infection mortality in lung transplant recipients[J]. Infection, 2023,DOI: 10.1007/s15010-023-02089-6[Epub ahead of print].
|
| [33] |
DOĞAN KAYA S, TAŞÇI E, KIRALI K. Evaluation of donor-derived bacterial infections in lung transplant recipients[J]. Turk Gogus Kalp Damar Cerrahisi Derg, 2023, 31(2): 269-274. DOI: 10.5606/tgkdc.dergisi.2023.23489.
|
| [34] |
中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所. 中国实体器官移植供者来源感染防控专家共识(2018版)[J]. 中华器官移植杂志, 2018, 39(1): 41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
Organ Transplantation Branch of Chinese Medical Association, Healthcare-Associated Infection Control of Chinese Preventive Medicine Association, Institute of Antibiotics of Huashan Hospital, Fudan University. The consensus on donor-derived infection control of solid organ transplantation in China(2018)[J]. Chin J Organ Transplant, 2018, 39(1): 41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
|
| [35] |
ANESI JA, BLUMBERG EA, HAN JH, et al. Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes[J]. Transpl Infect Dis, 2022, 24(1): e13783. DOI: 10.1111/tid.13783.
|
| [36] |
TEBANO G, GENEVE C, TANAKA S, et al. Epidemiology and risk factors of multidrug-resistant bacteria in respiratory samples after lung transplantation[J]. Transpl Infect Dis, 2016, 18(1): 22-30. DOI: 10.1111/tid.12471.
|
| [37] |
CARILLO C, PECORARO Y, ANILE M, et al. Colistin-based treatment of multidrug-resistant gram-negative bacterial pulmonary infections after lung transplantation[J]. Transplant Proc, 2019, 51(1): 202-205. DOI: 10.1016/j.transproceed.2018.04.068.
|
| [38] |
聂俊, 朱颖, 江波. 肺癌多学科协作存在的问题及对策[J]. 医学与哲学, 2018, 39(16): 4-6. DOI: 10.12014/j.issn.1002-0772.2018.08b.02.
NIE J, ZHU Y, JIANG B. The problems and solutions of lung cancer MDT[J]. Med Philos, 2018, 39(16): 4-6. DOI: 10.12014/j.issn.1002-0772.2018.08b.02.
|
Figures(1) / Tables(3)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: